Global IVIG Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 IVIG Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global IVIG Market Size Growth Rate by Product
  • 1.4.2 Injection
  • 1.4.3 Lyophilized Powder
• 1.5 Market by End User
  • 1.5.1 Global IVIG Market Size Growth Rate by End User
  • 1.5.2 Multiple Sclerosis (MS)
  • 1.5.3 Myasthenia Gravis (MG)
  • 1.5.4 Multifocal Motor Neuropathy (MMN)
  • 1.5.5 Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
  • 1.5.6 Dermatomyositis
  • 1.5.7 Polymyositis
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global IVIG Market Size
  • 2.1.1 Global IVIG Revenue 2014-2025
  • 2.1.2 Global IVIG Sales 2014-2025
• 2.2 IVIG Growth Rate by Regions
  • 2.2.1 Global IVIG Sales by Regions
  • 2.2.2 Global IVIG Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 IVIG Sales by Manufacturers
  • 3.1.1 IVIG Sales by Manufacturers
  • 3.1.2 IVIG Sales Market Share by Manufacturers
  • 3.1.3 Global IVIG Market Concentration Ratio (CR5 and HHI)
• 3.2 IVIG Revenue by Manufacturers
  • 3.2.1 IVIG Revenue by Manufacturers (2014-2019)
  • 3.2.2 IVIG Revenue Share by Manufacturers (2014-2019)
• 3.3 IVIG Price by Manufacturers
• 3.4 IVIG Manufacturing Base Distribution, Product Types
  • 3.4.1 IVIG Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers IVIG Product Type
  • 3.4.3 Date of International Manufacturers Enter into IVIG Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global IVIG Sales by Product
• 4.2 Global IVIG Revenue by Product
• 4.3 IVIG Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global IVIG Breakdown Data by End User

6 North America

• 6.1 North America IVIG by Countries
  • 6.1.1 North America IVIG Sales by Countries
  • 6.1.2 North America IVIG Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America IVIG by Product
• 6.3 North America IVIG by End User

7 Europe

• 7.1 Europe IVIG by Countries
  • 7.1.1 Europe IVIG Sales by Countries
  • 7.1.2 Europe IVIG Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe IVIG by Product
• 7.3 Europe IVIG by End User

8 Asia Pacific

• 8.1 Asia Pacific IVIG by Countries
  • 8.1.1 Asia Pacific IVIG Sales by Countries
  • 8.1.2 Asia Pacific IVIG Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific IVIG by Product
• 8.3 Asia Pacific IVIG by End User

9 Central & South America

• 9.1 Central & South America IVIG by Countries
  • 9.1.1 Central & South America IVIG Sales by Countries
  • 9.1.2 Central & South America IVIG Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America IVIG by Product
• 9.3 Central & South America IVIG by End User

10 Middle East and Africa

• 10.1 Middle East and Africa IVIG by Countries
  • 10.1.1 Middle East and Africa IVIG Sales by Countries
  • 10.1.2 Middle East and Africa IVIG Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa IVIG by Product
• 10.3 Middle East and Africa IVIG by End User

11 Company Profiles

• 11.1 Green Cross
  • 11.1.1 Green Cross Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Green Cross IVIG Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Green Cross IVIG Products Offered
  • 11.1.5 Green Cross Recent Development
• 11.2 BSV
  • 11.2.1 BSV Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 BSV IVIG Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 BSV IVIG Products Offered
  • 11.2.5 BSV Recent Development
• 11.3 Hualan Bio
  • 11.3.1 Hualan Bio Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Hualan Bio IVIG Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Hualan Bio IVIG Products Offered
  • 11.3.5 Hualan Bio Recent Development
• 11.4 RAAS
  • 11.4.1 RAAS Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 RAAS IVIG Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 RAAS IVIG Products Offered
  • 11.4.5 RAAS Recent Development
• 11.5 YUAN DA SHUYANG
  • 11.5.1 YUAN DA SHUYANG Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 YUAN DA SHUYANG IVIG Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 YUAN DA SHUYANG IVIG Products Offered
  • 11.5.5 YUAN DA SHUYANG Recent Development
• 11.6 Kangbao Bio
  • 11.6.1 Kangbao Bio Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Kangbao Bio IVIG Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Kangbao Bio IVIG Products Offered
  • 11.6.5 Kangbao Bio Recent Development
• 11.7 Tiantan Bio
  • 11.7.1 Tiantan Bio Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Tiantan Bio IVIG Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Tiantan Bio IVIG Products Offered
  • 11.7.5 Tiantan Bio Recent Development
• 11.8 Taibang Bio
  • 11.8.1 Taibang Bio Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Taibang Bio IVIG Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Taibang Bio IVIG Products Offered
  • 11.8.5 Taibang Bio Recent Development
• 11.9 Weiguang Bio
  • 11.9.1 Weiguang Bio Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Weiguang Bio IVIG Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Weiguang Bio IVIG Products Offered
  • 11.9.5 Weiguang Bio Recent Development
• 11.10 SIBP
  • 11.10.1 SIBP Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 SIBP IVIG Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 SIBP IVIG Products Offered
  • 11.10.5 SIBP Recent Development
• 11.11 TONROL
• 11.12 RUIDE Bio
• 11.13 BOYA Bio
• 11.14 RUIDE Bio
• 11.15 Xinxing Medicine
• 11.16 Weilun Bio
• 11.17 WIBP

12 Future Forecast

• 12.1 IVIG Market Forecast by Regions
  • 12.1.1 Global IVIG Sales Forecast by Regions 2019-2025
  • 12.1.2 Global IVIG Revenue Forecast by Regions 2019-2025
• 12.2 IVIG Market Forecast by Product
  • 12.2.1 Global IVIG Sales Forecast by Product 2019-2025
  • 12.2.2 Global IVIG Revenue Forecast by Product 2019-2025
• 12.3 IVIG Market Forecast by End User
• 12.4 North America IVIG Forecast
• 12.5 Europe IVIG Forecast
• 12.6 Asia Pacific IVIG Forecast
• 12.7 Central & South America IVIG Forecast
• 12.8 Middle East and Africa IVIG Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 IVIG Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details